Antimicrobial drug discovery through bacteriophage genomics

Jing Liu, Mohammed Dehbi, Greg Moeck, Francis Arhin, Pascale Banda, Dominique Bergeron, Mario Callejo, Vincent Ferretti, Nhuan Ha, Tony Kwan, John McCarty, Ramakrishnan Srikumar, Dan Williams, Jinzi J. Wu, Philippe Gros, Jerry Pelletier, Michael DuBow

Research output: Contribution to journalArticle

153 Citations (Scopus)

Abstract

Over evolutionary time bacteriophages have developed unique proteins that arrest critical cellular processes to commit bacterial host metabolism to phage reproduction. Here, we apply this concept of phage-mediated bacterial growth inhibition to antibiotic discovery. We sequenced 26 Staphylococcus aureus phages and identified 31 novel polypeptide families that inhibited growth upon expression in S. aureus. The cellular targets for some of these polypeptides were identified and several were shown to be essential components of the host DNA replication and transcription machineries. The interaction between a prototypic pair, ORF104 of phage 77 and Dnal, the putative helicase loader of S. aureus, was then used to screen for small molecule inhibitors. Several compounds were subsequently found to inhibit both bacterial growth and DNA synthesis. Our results suggest that mimicking the growth-inhibitory effect of phage polypeptides by a chemical compound, coupled with the plethora of phages on earth, will yield new antibiotics to combat infectious diseases.

Original languageEnglish
Pages (from-to)185-191
Number of pages7
JournalNature Biotechnology
Volume22
Issue number2
DOIs
Publication statusPublished - 1 Feb 2004
Externally publishedYes

Fingerprint

Bacteriophages
Drug Discovery
Genomics
Polypeptides
Staphylococcus aureus
Growth
Peptides
Antibiotics
Staphylococcus Phages
DNA
Anti-Bacterial Agents
Bacterial DNA
Loaders
Chemical compounds
DNA Replication
Transcription
Reproduction
Communicable Diseases
Metabolism
Earth (planet)

ASJC Scopus subject areas

  • Microbiology

Cite this

Liu, J., Dehbi, M., Moeck, G., Arhin, F., Banda, P., Bergeron, D., ... DuBow, M. (2004). Antimicrobial drug discovery through bacteriophage genomics. Nature Biotechnology, 22(2), 185-191. https://doi.org/10.1038/nbt932

Antimicrobial drug discovery through bacteriophage genomics. / Liu, Jing; Dehbi, Mohammed; Moeck, Greg; Arhin, Francis; Banda, Pascale; Bergeron, Dominique; Callejo, Mario; Ferretti, Vincent; Ha, Nhuan; Kwan, Tony; McCarty, John; Srikumar, Ramakrishnan; Williams, Dan; Wu, Jinzi J.; Gros, Philippe; Pelletier, Jerry; DuBow, Michael.

In: Nature Biotechnology, Vol. 22, No. 2, 01.02.2004, p. 185-191.

Research output: Contribution to journalArticle

Liu, J, Dehbi, M, Moeck, G, Arhin, F, Banda, P, Bergeron, D, Callejo, M, Ferretti, V, Ha, N, Kwan, T, McCarty, J, Srikumar, R, Williams, D, Wu, JJ, Gros, P, Pelletier, J & DuBow, M 2004, 'Antimicrobial drug discovery through bacteriophage genomics', Nature Biotechnology, vol. 22, no. 2, pp. 185-191. https://doi.org/10.1038/nbt932
Liu J, Dehbi M, Moeck G, Arhin F, Banda P, Bergeron D et al. Antimicrobial drug discovery through bacteriophage genomics. Nature Biotechnology. 2004 Feb 1;22(2):185-191. https://doi.org/10.1038/nbt932
Liu, Jing ; Dehbi, Mohammed ; Moeck, Greg ; Arhin, Francis ; Banda, Pascale ; Bergeron, Dominique ; Callejo, Mario ; Ferretti, Vincent ; Ha, Nhuan ; Kwan, Tony ; McCarty, John ; Srikumar, Ramakrishnan ; Williams, Dan ; Wu, Jinzi J. ; Gros, Philippe ; Pelletier, Jerry ; DuBow, Michael. / Antimicrobial drug discovery through bacteriophage genomics. In: Nature Biotechnology. 2004 ; Vol. 22, No. 2. pp. 185-191.
@article{2e7cf9d7470a464e810c99660aef7317,
title = "Antimicrobial drug discovery through bacteriophage genomics",
abstract = "Over evolutionary time bacteriophages have developed unique proteins that arrest critical cellular processes to commit bacterial host metabolism to phage reproduction. Here, we apply this concept of phage-mediated bacterial growth inhibition to antibiotic discovery. We sequenced 26 Staphylococcus aureus phages and identified 31 novel polypeptide families that inhibited growth upon expression in S. aureus. The cellular targets for some of these polypeptides were identified and several were shown to be essential components of the host DNA replication and transcription machineries. The interaction between a prototypic pair, ORF104 of phage 77 and Dnal, the putative helicase loader of S. aureus, was then used to screen for small molecule inhibitors. Several compounds were subsequently found to inhibit both bacterial growth and DNA synthesis. Our results suggest that mimicking the growth-inhibitory effect of phage polypeptides by a chemical compound, coupled with the plethora of phages on earth, will yield new antibiotics to combat infectious diseases.",
author = "Jing Liu and Mohammed Dehbi and Greg Moeck and Francis Arhin and Pascale Banda and Dominique Bergeron and Mario Callejo and Vincent Ferretti and Nhuan Ha and Tony Kwan and John McCarty and Ramakrishnan Srikumar and Dan Williams and Wu, {Jinzi J.} and Philippe Gros and Jerry Pelletier and Michael DuBow",
year = "2004",
month = "2",
day = "1",
doi = "10.1038/nbt932",
language = "English",
volume = "22",
pages = "185--191",
journal = "Nature Biotechnology",
issn = "1087-0156",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Antimicrobial drug discovery through bacteriophage genomics

AU - Liu, Jing

AU - Dehbi, Mohammed

AU - Moeck, Greg

AU - Arhin, Francis

AU - Banda, Pascale

AU - Bergeron, Dominique

AU - Callejo, Mario

AU - Ferretti, Vincent

AU - Ha, Nhuan

AU - Kwan, Tony

AU - McCarty, John

AU - Srikumar, Ramakrishnan

AU - Williams, Dan

AU - Wu, Jinzi J.

AU - Gros, Philippe

AU - Pelletier, Jerry

AU - DuBow, Michael

PY - 2004/2/1

Y1 - 2004/2/1

N2 - Over evolutionary time bacteriophages have developed unique proteins that arrest critical cellular processes to commit bacterial host metabolism to phage reproduction. Here, we apply this concept of phage-mediated bacterial growth inhibition to antibiotic discovery. We sequenced 26 Staphylococcus aureus phages and identified 31 novel polypeptide families that inhibited growth upon expression in S. aureus. The cellular targets for some of these polypeptides were identified and several were shown to be essential components of the host DNA replication and transcription machineries. The interaction between a prototypic pair, ORF104 of phage 77 and Dnal, the putative helicase loader of S. aureus, was then used to screen for small molecule inhibitors. Several compounds were subsequently found to inhibit both bacterial growth and DNA synthesis. Our results suggest that mimicking the growth-inhibitory effect of phage polypeptides by a chemical compound, coupled with the plethora of phages on earth, will yield new antibiotics to combat infectious diseases.

AB - Over evolutionary time bacteriophages have developed unique proteins that arrest critical cellular processes to commit bacterial host metabolism to phage reproduction. Here, we apply this concept of phage-mediated bacterial growth inhibition to antibiotic discovery. We sequenced 26 Staphylococcus aureus phages and identified 31 novel polypeptide families that inhibited growth upon expression in S. aureus. The cellular targets for some of these polypeptides were identified and several were shown to be essential components of the host DNA replication and transcription machineries. The interaction between a prototypic pair, ORF104 of phage 77 and Dnal, the putative helicase loader of S. aureus, was then used to screen for small molecule inhibitors. Several compounds were subsequently found to inhibit both bacterial growth and DNA synthesis. Our results suggest that mimicking the growth-inhibitory effect of phage polypeptides by a chemical compound, coupled with the plethora of phages on earth, will yield new antibiotics to combat infectious diseases.

UR - http://www.scopus.com/inward/record.url?scp=0742323372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0742323372&partnerID=8YFLogxK

U2 - 10.1038/nbt932

DO - 10.1038/nbt932

M3 - Article

VL - 22

SP - 185

EP - 191

JO - Nature Biotechnology

JF - Nature Biotechnology

SN - 1087-0156

IS - 2

ER -